UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing

Antimicrobial agents and chemotherapy, 2023-07, Vol.67 (7), p.e0007723-e0007723

2023

Volltextzugriff (PDF)

Pharmacokinetic studies in children: recommendations for practice and research

Archives of disease in childhood, 2018-07, Vol.103 (7), p.695

2018

Volltextzugriff (PDF)

SARS-CoV-2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy

CPT: pharmacometrics and systems pharmacology, 2023-10, Vol.12 (10), p.1450-1460

2023

Volltextzugriff (PDF)

Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines

PloS one, 2021-05, Vol.16 (5), p.e0252223-e0252223

2021

Volltextzugriff (PDF)

Understanding and applying pharmacometric modelling and simulation in clinical practice and research

British journal of clinical pharmacology, 2017-02, Vol.83 (2), p.247-254

Standing, Joseph F.

2017

Volltextzugriff (PDF)

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1908-1916

2018

Volltextzugriff (PDF)

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Nature communications, 2024-02, Vol.15 (1), p.1652-1652, Article 1652

2024

Volltextzugriff (PDF)

Effect of age on the performance of bispectral and entropy indices during sevoflurane pediatric anesthesia: a pharmacometric study

Pediatric anesthesia, 2017-04, Vol.27 (4), p.399-408

2017

Volltextzugriff (PDF)

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

PLoS medicine, 2022-10, Vol.19 (10), p.e1004120

2022

Volltextzugriff (PDF)

Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic?

Clinical pharmacology and therapeutics, 2023-02, Vol.113 (2), p.207-209

Standing, Joseph F.

2023

Volltextzugriff (PDF)

Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants

Journal of antimicrobial chemotherapy, 2022-11, Vol.77 (12), p.3524-3524

Standing, Joseph F

2022

Volltextzugriff (PDF)

Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.2046-2047

Standing, Joseph F

2022

Volltextzugriff (PDF)

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial

Clinical pharmacology and therapeutics, 2020-08, Vol.108 (2), p.264-273

2020

Volltextzugriff (PDF)

Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use

Frontiers in plant science, 2023-02, Vol.14, p.1126470-1126470

2023

Volltextzugriff (PDF)

Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation

Frontiers in immunology, 2018-11, Vol.9, p.2547-2547

2018

Volltextzugriff (PDF)

Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model

Frontiers in immunology, 2022-07, Vol.13, p.903063

2022

Volltextzugriff (PDF)

Quantitative Clinical Pharmacology Input to SARS‐CoV‐2 Therapeutics Should Be Based on Robust Data

Clinical pharmacology and therapeutics, 2020-08, Vol.108 (2), p.187-187

Standing, Joseph F.

2020

Volltextzugriff (PDF)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

BMJ open, 2023-08, Vol.13 (8), p.e069176-e069176

2023

Volltextzugriff (PDF)

Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial

Trials, 2021-03, Vol.22 (1), p.193-4, Article 193

2021

Volltextzugriff (PDF)

Learning and confirming in publicly funded antiviral trials

The Lancet infectious diseases, 2023-02, Vol.23 (2), p.132-133

2023

Volltextzugriff (PDF)

Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation

Microbiome, 2022-06, Vol.10 (1), p.89-89, Article 89

2022

Volltextzugriff (PDF)

What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies

Blood coagulation & fibrinolysis, 2019-01, Vol.30 (1), p.1

2019

Volltextzugriff (PDF)

Short versus Long Infusion of Meropenem in Very-Low-Birth-Weight Neonates

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4760-4764

2012

Volltextzugriff (PDF)

Fentanyl dosage for preterm infants suggested by a pharmacokinetic, -dynamic, and -genetic model

Pediatric research, 2024-07

2024

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(126)
Buchkapitel
(2)

Sprache

Englisch
(128)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(106)
Humans
(93)
Pharmacology & Pharmacy
(69)
Child
(47)
Pharmacokinetics
(33)
Infant, Newborn
(29)
Microbiology
(29)
Infant
(26)
Infectious Diseases
(25)
Child, Preschool
(23)
Pediatrics
(23)
Female
(22)
Male
(22)
Models, Biological
(22)
Pharmacodynamics
(18)
Pharmacology
(18)
Adolescent
(16)
Dose-Response Relationship, Drug
(16)
Anti-Bacterial Agents - Pharmacokinetics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing

Pharmacokinetic studies in children: recommendations for practice and research

SARS-CoV-2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy

Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines

Understanding and applying pharmacometric modelling and simulation in clinical practice and research

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Effect of age on the performance of bispectral and entropy indices during sevoflurane pediatric anesthesia: a pharmacometric study

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic?

Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants

Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial

Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use

Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation

Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model

Quantitative Clinical Pharmacology Input to SARS‐CoV‐2 Therapeutics Should Be Based on Robust Data

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial

Learning and confirming in publicly funded antiviral trials

Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation

What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies

Short versus Long Infusion of Meropenem in Very-Low-Birth-Weight Neonates

Fentanyl dosage for preterm infants suggested by a pharmacokinetic, -dynamic, and -genetic model

Suchergebnisse filtern